Fair Value Measurements (Schedule Of Fair Value Hierarchy, Assets (Liabilities) Carried At Fair Value) (Details) - USD ($) $ in Thousands				9 Months Ended
	Feb. 10, 2016	Nov. 30, 2015	Oct. 03, 2014	Mar. 31, 2016	Mar. 31, 2015	Jan. 29, 2016	Jun. 30, 2015
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Business Combination, Consideration Transferred	$ 71,800
business combination, contingent consideration arrangement, payment				$ (9,900)	$ 0
Fair Value, Measurement with Unobservable Inputs Reconciliations, Recurring Basis, Liability Value				4,700			$ 7,300
Long-term Debt, Fair Value				99,000
Interest Rate Derivative Instruments				(700)			700
Foreign Currency Fair Value Hedge Derivative at Fair Value, Net				(500)			(5,600)
Business Acquisition, Contingent Consideration, at Fair Value				(4,700)			(7,300)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings				(8,200)	$ 5,000
Liabilities, Fair Value Disclosure, Recurring				(5,900)			(12,200)
Fair Value, Inputs, Level 1 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Interest Rate Derivative Instruments				0			0
Foreign Currency Fair Value Hedge Derivative at Fair Value, Net				0			0
Business Acquisition, Contingent Consideration, at Fair Value				0			0
Total				0			0
Fair Value, Inputs, Level 2 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Interest Rate Derivative Instruments				(700)			700
Foreign Currency Fair Value Hedge Derivative at Fair Value, Net				(500)			(5,600)
Business Acquisition, Contingent Consideration, at Fair Value				0			0
Liabilities, Fair Value Disclosure, Recurring				(1,200)			(4,900)
Fair Value, Inputs, Level 3 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Interest Rate Derivative Instruments				0			0
Foreign Currency Fair Value Hedge Derivative at Fair Value, Net				0			0
Business Acquisition, Contingent Consideration, at Fair Value				(4,700)			(7,300)
Liabilities, Fair Value Disclosure, Recurring				$ (4,700)			$ (7,300)
ClinIntel Acquisition [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
business combination, contingent consideration arrangement, payment						$ (14,100)
Payments to Acquire Businesses, Gross			$ 8,800
Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High			15,000			$ 0
Health Advances Acquisition [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Business Combination, Consideration Transferred	$ 67,300
Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High			$ 15,800
Fair Value Inputs, Discount Rate				1.00%
Business Acquisition, Contingent Consideration, at Fair Value				$ (4,500)
Selling, General and Administrative Expenses [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings		$ 0		$ 8,200